← All trials
NCT01379898
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2011
- Primary completion
- May 1, 2017
- Completion date
- Dec 1, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 134
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of GroningenLead sponsor
- Onze Lieve Vrouw HospitalCollaborator
- Medical Center HaaglandenOverall official - principal investigator
- Canisius-Wilhelmina HospitalOverall official - principal investigator
- Atrium Medical CenterOverall official - principal investigator
- Utrecht UniversityOverall official - principal investigator
- University of GroningenOverall official - principal investigator
- Medical Center LeeuwardenOverall official - principal investigator
- Medisch Spectrum TwenteOverall official - principal investigator
- Maastricht UniversityOverall official - principal investigator
- University of GroningenStudy director
- Radboud UniversityOverall official - principal investigator
- Radboud UniversityCollaborator
- Canisius-Wilhelmina HospitalCollaborator
- Atrium Medical CenterCollaborator
- Leiden UniversityCollaborator
- Utrecht UniversityCollaborator
- Medisch Spectrum TwenteCollaborator
- Maastricht UniversityCollaborator
- University of AmsterdamCollaborator
- University of GroningenReponsible party - principal investigator
- Free University of AmsterdamOverall official - principal investigator
- Isala Clinics, Zwolle, The NetherlandsCollaborator
- Isala Clinics, Zwolle, The NetherlandsOverall official - principal investigator
- St. Antonius Hospital, NieuwegeinCollaborator
- St. Antonius Hospital, NieuwegeinOverall official - principal investigator
- University of AmsterdamOverall official - principal investigator
- Erasmus University RotterdamOverall official - principal investigator
- Erasmus University RotterdamCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.